Most Active InvestorsFind investorsBlogPricing
Start for free
Start for free
Syno Capital logo

Syno Capital

North America, New York, United States, New York

Description

Syno Capital is a principal investment firm focused on life science and healthcare sector investments in New York.

Investor Profile

Syno Capital has backed more than 8 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 13% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series B (50%)
  • Series A (25%)
  • Series Unknown (13%)
  • Series D (13%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Wellness
  • Pharmaceutical
  • Personal Health
  • Life Science
  • Medical Device
  • Elder Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Syno Capital frequently co-invest with?

Mountain Group Capital
Mountain Group Capital
North America, Tennessee, United States, Nashville
Co-Investments: 2
E Squared Capital Management
E Squared Capital Management
North America, New York, United States, New York
Co-Investments: 2
Hatteras Venture Partners
Hatteras Venture Partners
North America, North Carolina, United States, Durham
Co-Investments: 3
LabCorp
LabCorp
North America, North Carolina, United States, Burlington
Co-Investments: 2
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 3
180 Degree Capital
180 Degree Capital
North America, New Jersey, United States, Montclair
Co-Investments: 2
DEFTA Partners
DEFTA Partners
North America, California, United States, San Francisco
Co-Investments: 2
KF
KTB-KORUS Fund
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 2
THE CATALYTIC IMPACT FOUNDATION (CIF)
THE CATALYTIC IMPACT FOUNDATION (CIF)
North America, New York, United States, New York
Co-Investments: 1
EF
Co-Investments: 2

Which angels does Syno Capital often collaborate with?

SS
Steve Seigel
North America, California, United States, Los Angeles
Shared Deals: 1
Derek Schueren
Derek Schueren
North America, California, United States, San Francisco
Shared Deals: 1
FB
Franklin Berger
North America, New York, United States, New York
Shared Deals: 2

What are some of recent deals done by Syno Capital?

Applied Therapeutics

New York, New York, United States

Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.

BiotechnologyHealth CareTherapeuticsWellness
Series BFeb 1, 2019
Amount Raised: $25,000,000
PhaseBio Pharmaceuticals

Malvern, Pennsylvania, United States

PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.

BiotechnologyMedicalMedical DevicePharmaceutical
Series DSep 5, 2018
Amount Raised: $34,000,000
TCR2

Cambridge, Massachusetts, United States

TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuC™ platform.

BiotechnologyHealth CareLife ScienceMedicalPharmaceuticalTherapeutics
Series BMar 21, 2018
Amount Raised: $125,000,000
ORIG3N

Boston, Massachusetts, United States

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

BiotechnologyHealth CareMedicalPersonal Health
Series UnknownJun 27, 2017
Amount Raised: $20,000,000
Applied Therapeutics

New York, New York, United States

Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.

BiotechnologyHealth CareTherapeuticsWellness
Series AFeb 8, 2017
Amount Raised: $6,067,875
Honor

Concord, California, United States

Honor is a senior care network and technology platform that offers personalized care to improve the in-home care experience.

Elder CareHealth CareHome Health CareMedical
Series BAug 5, 2016
Amount Raised: $45,000,000
ORIG3N

Boston, Massachusetts, United States

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

BiotechnologyHealth CareMedicalPersonal Health
Series ADec 12, 2015
Amount Raised: $12,500,000
LungLife AI

Thousand Oaks, California, United States

LungLife AI is a molecular diagnostics company that involves in the early detection and treatment of cancer.

Artificial Intelligence (AI)BiotechnologyHealth DiagnosticsMachine LearningMedical
Series BJun 17, 2015
Amount Raised: $25,500,000

Find More Investors Like Syno Capital

Discover similar investors in our database and build your perfect investor list.

series_b InvestorsInvestors in New YorkBrowse All InvestorsTop Investors

Need help with your fundraising strategy?Read our fundraising guides

Decorative background shape
Decorative background shape

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Most Active Investors Find InvestorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator

Investors By Location

San FranciscoNew York CityBostonLos AngelesChicagoLondonParisIndiaSingaporeTel Aviv

Investors By Stage

Angel InvestorsPre-Seed InvestorsSeed InvestorsSeries A InvestorsSeries B InvestorsSeries C InvestorsSeries D Investors